Imatinib Completed Phase 1 Trials for Mesothelioma Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00402766Cisplatin, Pemetrexed, and Imatinib Mesylate in Malignant Mesothelioma